University of Vermont
University of Vermont
Burlington, Vermont, United States26 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | bronchial disorder, bronchiectasis, respiratory system disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06872892 | |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-09-30 | NCT06238622 | |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 3 | 2026-09-18 | NCT06541704 | |
| SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. | nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 2 | 2026-09-16 | NCT06614322 | |
| An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma | large B-cell lymphoma | Active, not recruiting | Phase 3 | 2026-09-11 | NCT06047080 | |
| CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) | cardiovascular disorder, heart disorder, pericarditis | Recruiting | Phase 3 | 2026-09-10 | NCT06708299 | |
| Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute leukemia, acute myeloid leukemia, acute myeloid leukemia with mutated NPM1, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-20 | NCT06001788 | |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-07-27 | NCT04951622 | |
| PROACTIVE-HF IDE Trial Heart Failure NYHA Class III | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-07-24 | NCT04089059 | |
| Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-07-06 | NCT05685745 | |
| PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-06-29 | NCT05934487 | |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-06-26 | NCT04045665 | |
| Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2026-06-24 | NCT01586910 | |
| Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2026-05-15 | NCT06564142 | |
| Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Not applicable | 2026-05-13 | NCT06670079 | |
| Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-05-12 | NCT04150887 | |
| Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-04-02 | NCT04851613 | |
| RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Not yet recruiting | Not applicable | 2026-02-27 | NCT07440641 | |
| Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not applicable | 2026-02-12 | NCT07406594 | |
| His-Bundle Corrective Pacing in Heart Failure | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Right Bundle-Branch Block, atrioventricular dissociation, cardiovascular disorder, heart disorder, heart failure, progressive familial heart block, type 1A | Recruiting | Not applicable | 2026-02-09 | NCT05265520 | |
| Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies | GI Cancers | Enrolling by invitation | Phase 2 | 2026-02-05 | NCT06648785 | |
| Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2 | Food Security | Recruiting | Not applicable | 2025-11-26 | NCT07251283 | |
| Fatty Acid Modulation of Brain Function in Older Adults | Aging | Recruiting | Not applicable | 2025-09-17 | NCT06192407 | |
| Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Infections, Mycobacterium Infections, Nontuberculous, bacterial infectious disease, cystic fibrosis, gram-positive bacterial infections, hereditary disease, lung disorder, mycobacterial infectious disease, pancreas disorder, pulmonary non-tuberculous mycobacterial infection, respiratory system disorder | Enrolling by invitation | Not stated | 2025-05-21 | NCT06262282 | |
| PRESERVE & CONNECT: Impact Study of the BPC | injury | Recruiting | Not applicable | 2025-04-17 | NCT06160050 |